ACCPLPharmaceuticals
ACCRETION PHARMA LIMITED — PE Ratio & Valuation Analysis
₹63.55
-0.08%
Current P/E11.35xPrice to earnings
Industry P/E31.77xSector average
✅
64.3% Discount to Industry
ACCPL P/E 11.35x vs sector avg 31.77x
💡
Understanding ACCRETION PHARMA LIMITED Valuation
ACCRETION PHARMA LIMITED (ACCPL) currently trades at 11.35x earnings. The Pharmaceuticals sector average PE is 31.77x. ACCPL is trading at a discount to peers — may indicate relative value. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
65.35%
Dividend Yield
0.00%
More on ACCRETION PHARMA LIMITED
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.